Empyrean Capital Partners’s Envoy Medical Warrant COCHW Stock Holding History

Empyrean Capital Partners’s Portfolio COCHW Stock Details COCHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.98K	Hold	75,000	–	–	﹤0.01%	123
2025 Q4	$2.92K	Hold	75,000	–	–	﹤0.01%	93
2025 Q3	$2.82K	Hold	75,000	–	–	﹤0.01%	85
2025 Q2	$2.65K	Hold	75,000	–	–	﹤0.01%	74
2025 Q1	$2.48K	Hold	75,000	–	–	﹤0.01%	58
2024 Q4	$3.5K	Hold	75,000	–	–	﹤0.01%	70
2024 Q3	$5.96K	Hold	75,000	–	–	﹤0.01%	67
2024 Q2	$3.75K	Hold	75,000	–	–	﹤0.01%	68
2024 Q1	$7.99K	Hold	75,000	–	–	﹤0.01%	64
2023 Q4	$1.5K	Hold	75,000	–	–	﹤0.01%	57
2023 Q3	$6.67K	Hold	75,000	–	–	﹤0.01%	70
2023 Q2	$3.5K	Hold	75,000	–	–	﹤0.01%	68
2023 Q1	$2.64K	Hold	75,000	–	–	﹤0.01%	87
2022 Q4	$2.85K	Hold	75,000	–	–	﹤0.01%	110
2022 Q3	$5K	Hold	75,000	–	–	﹤0.01%	125
2022 Q2	$8K	Hold	75,000	–	–	﹤0.01%	150
2022 Q1	$19K	Hold	75,000	–	–	﹤0.01%	194
2021 Q4	$59K	Buy	+75,000	New	+$54.9K	﹤0.01%	181

Other funds holding COCHW

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return

Empyrean Capital Partners's COCHW Position: Q1 2026 in Review

Empyrean Capital Partners held its Envoy Medical Warrant (COCHW) position steady in Q1 2026 at 75,000 shares worth $4.98K. The position accounts for ﹤0.01% of the portfolio, ranked #123.

Empyrean Capital Partners first reported a position in COCHW in Q4 2021 and has held it in 18 quarters since. The position peaked at $59K in Q4 2021. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

Empyrean Capital Partners held 75,000 shares of Envoy Medical Warrant worth $4.98K as of Q1 2026.
Empyrean Capital Partners left its Envoy Medical Warrant share count unchanged in Q1 2026.
Envoy Medical Warrant made up ﹤0.01% of Empyrean Capital Partners's portfolio in Q1 2026, its #123 holding.
Empyrean Capital Partners first reported a position in Envoy Medical Warrant in Q4 2021 and has held it in 18 quarters since.
Empyrean Capital Partners's Envoy Medical Warrant position peaked at $59K in Q4 2021.
34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on Empyrean Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.